|
Dezhan Healthcare Company Limited (000813.SZ) DCF -Bewertung
CN | Healthcare | Drug Manufacturers - Specialty & Generic | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Dezhan Healthcare Company Limited (000813.SZ) Bundle
Unser (000813SZ) DCF-Taschenrechner wurde für die Genauigkeit entwickelt und ermöglicht es Ihnen, die Bewertung von Dezhan Healthcare Company Limited unter Verwendung realer Finanzdaten zu bewerten und vollständige Flexibilität zu bieten, um alle wesentlichen Parameter für erweiterte Projektionen zu optimieren.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,775.0 | 962.9 | 734.5 | 570.9 | 498.1 | 368.0 | 271.8 | 200.8 | 148.4 | 109.6 |
| Revenue Growth, % | 0 | -45.75 | -23.72 | -22.28 | -12.75 | -26.12 | -26.12 | -26.12 | -26.12 | -26.12 |
| EBITDA | 407.3 | 432.9 | 59.7 | -1.3 | 219.4 | 88.2 | 65.2 | 48.1 | 35.6 | 26.3 |
| EBITDA, % | 22.95 | 44.96 | 8.13 | -0.23001 | 44.04 | 23.97 | 23.97 | 23.97 | 23.97 | 23.97 |
| Depreciation | 54.6 | 71.4 | 87.1 | 101.2 | 88.9 | 42.6 | 31.5 | 23.3 | 17.2 | 12.7 |
| Depreciation, % | 3.08 | 7.41 | 11.85 | 17.72 | 17.84 | 11.58 | 11.58 | 11.58 | 11.58 | 11.58 |
| EBIT | 352.7 | 361.5 | -27.4 | -102.5 | 130.5 | 45.6 | 33.7 | 24.9 | 18.4 | 13.6 |
| EBIT, % | 19.87 | 37.54 | -3.73 | -17.95 | 26.2 | 12.39 | 12.39 | 12.39 | 12.39 | 12.39 |
| Total Cash | 3,573.7 | 3,514.4 | 1,892.1 | 2,599.1 | 2,796.4 | 368.0 | 271.8 | 200.8 | 148.4 | 109.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 921.9 | 901.4 | 369.9 | 698.3 | 203.4 | 247.8 | 183.1 | 135.3 | 99.9 | 73.8 |
| Account Receivables, % | 51.94 | 93.62 | 50.36 | 122.32 | 40.83 | 67.35 | 67.35 | 67.35 | 67.35 | 67.35 |
| Inventories | 331.7 | 313.0 | 300.0 | 250.9 | 207.6 | 130.7 | 96.6 | 71.4 | 52.7 | 38.9 |
| Inventories, % | 18.69 | 32.5 | 40.85 | 43.95 | 41.67 | 35.53 | 35.53 | 35.53 | 35.53 | 35.53 |
| Accounts Payable | 33.0 | 53.6 | 31.3 | 140.8 | 26.3 | 30.6 | 22.6 | 16.7 | 12.4 | 9.1 |
| Accounts Payable, % | 1.86 | 5.57 | 4.26 | 24.67 | 5.29 | 8.33 | 8.33 | 8.33 | 8.33 | 8.33 |
| Capital Expenditure | -65.1 | -110.3 | -126.9 | -67.6 | -159.7 | -56.2 | -41.5 | -30.6 | -22.6 | -16.7 |
| Capital Expenditure, % | -3.67 | -11.45 | -17.28 | -11.83 | -32.07 | -15.26 | -15.26 | -15.26 | -15.26 | -15.26 |
| Tax Rate, % | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 |
| EBITAT | 306.4 | 294.5 | -71.0 | -129.8 | 132.8 | 42.7 | 31.5 | 23.3 | 17.2 | 12.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -924.6 | 315.4 | 411.4 | -266.0 | 485.7 | 65.8 | 112.4 | 83.1 | 61.4 | 45.3 |
| WACC, % | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 314.4 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 47 | |||||||||
| Terminal Value | 2,358 | |||||||||
| Present Terminal Value | 1,762 | |||||||||
| Enterprise Value | 2,077 | |||||||||
| Net Debt | -2,789 | |||||||||
| Equity Value | 4,866 | |||||||||
| Diluted Shares Outstanding, MM | 2,181 | |||||||||
| Equity Value Per Share | 2.23 |
What You Will Receive
- Genuine 000813SZ Financials: Access to both historical and projected data for precise valuation.
- Customizable Parameters: Adjust inputs like WACC, tax rates, revenue growth, and capital investments.
- Real-Time Calculations: Intrinsic value and NPV are updated automatically.
- Scenario Analysis: Evaluate various scenarios to assess Dezhan Healthcare's future performance.
- User-Friendly Design: Designed for professionals, yet easy for newcomers to navigate.
Key Highlights
- Genuine Dezhan Financials: Gain access to precise pre-loaded historical data and future forecasts.
- Adjustable Forecast Parameters: Modify the yellow-highlighted fields such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to effectively illustrate your valuation outcomes.
- Suitable for All Skill Levels: An easy-to-navigate design tailored for investors, CFOs, and consultants.
How It Works
- Step 1: Download the prebuilt Excel template featuring data for Dezhan Healthcare Company Limited (000813SZ).
- Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Adjust forecasts and assumptions in the editable yellow cells (WACC, growth rates, margins).
- Step 4: Instantly see the recalculated results, including the intrinsic value of Dezhan Healthcare Company Limited (000813SZ).
- Step 5: Use the outputs to make well-informed investment decisions or to create comprehensive reports.
Why Choose Dezhan Healthcare's Calculator?
- Precision: Utilizes real Dezhan Healthcare financials for unparalleled data reliability.
- Adaptability: Crafted to allow users the freedom to test and adjust inputs effortlessly.
- Efficiency: Eliminate the complexities of constructing a DCF model from the ground up.
- Expert-Level: Engineered with the accuracy and functionality expected by CFOs.
- Intuitive Design: Simple to navigate, making it accessible for users without extensive financial modeling skills.
Who Should Use This Product?
- Investors: Assess Dezhan Healthcare Company Limited’s (000813SZ) valuation prior to making investment decisions.
- CFOs and Financial Analysts: Enhance valuation procedures and evaluate financial forecasts.
- Startup Founders: Understand how large public companies like Dezhan Healthcare are appraised.
- Consultants: Provide detailed valuation reports for your clients pertaining to Dezhan Healthcare Company Limited.
- Students and Educators: Utilize real-time data to learn and teach valuation methodologies focused on (000813SZ).
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Dezhan Healthcare Company Limited (000813SZ), including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for the Weighted Average Cost of Capital (WACC), featuring parameters such as Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models displaying intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to support in-depth analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios specifically for Dezhan Healthcare Company Limited (000813SZ).
- Dashboard and Charts: A visual summary of valuation outputs and assumptions for straightforward analysis of results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.